Opsonix, Inc.
Biotechnology - Cambridge, Massachusetts, United States
Opsonix, Inc. Employees
Opsonix, Inc. Details
Opsonix is developing and commercializing a pathogen-extracting therapy that uses its proprietary pathogen-capture proteins to remove infectious microbes and the toxins they release from circulating blood, offering a new broad-spectrum approach to transform the treatment of blood-borne infectious diseases, including sepsis.Opsonix's pathogen-capture proteins are engineered versions of human opsonins—molecular components of the innate immune system that help to clear our bodies of pathogens and released toxins. Our most advanced pathogen-capture protein, FcMBL, binds all types of microorganisms, including bacteria, fungi, parasites and viruses, as well as many toxins. The pathogen-extracting therapy incorporates FcMBL into an extracorporeal medical device to remove infectious agents from circulating blood in patients with systemic infections that are the cause of sepsis.
Opsonix, Inc. Technologies
Domain Name Services
Cloudflare DNS
CMS
WordPress.org
Hosting
CloudFlare Hosting
Other
Mobile Friendly